AstraZeneca is headquartered in Shanghai China, and has production bases in Wuxi and Taizhou, Jiangsu Province. Most of the cleanroom panel in the clean workshop of its production base in Taizhou are MAX products.
In China, AstraZeneca’s main business focuses on the areas of most in need of treatment for Chinese patients, including cardiovascular, metabolic diseases, tumors, respiration, digestion and anesthesia.